Turkey And Industry Tussle On Policy Following Price Cuts
This article was originally published in PharmAsia News
Executive Summary
Drug companies and the government in Turkey are tussling over savings gleaned from discounts and price cuts between 2010 and 2012 – pointing to a larger debate over how to keep health spending in check as Ankara seeks to make the sector a cornerstone of economic policy in the new national budget cycle.